Quality of life and MISS 21 outcomes by symptom resolution
| ALL | ED | General practice | Pharmacy | |||||
|---|---|---|---|---|---|---|---|---|
| n | Mean (SD) | n | Mean (SD) | n | Mean (SD) | n | Mean (SD) | |
| EQ-5D-3L utility baseline | ||||||||
| Resolved | 101 | 0.74 (0.22) | 18 | 0.58 (0.28) | 40 | 0.76 (0.22) | 43 | 0.79 (0.17) |
| Not resolved | 148 | 0.64 (0.28) | 29 | 0.49 (0.32) | 69 | 0.64 (0.26) | 50 | 0.73 (0.26) |
| p Value* | 0.002 | 0.362 | 0.01 | 0.195 | ||||
| EQ-5D-3L utility follow-up | ||||||||
| Resolved | 99 | 0.93 (0.12) | 18 | 0.94 (0.09) | 39 | 0.95 (0.10) | 42 | 0.91 (0.15) |
| Not resolved | 150 | 0.71 (0.26) | 30 | 0.62 (0.31) | 67 | 0.71 (0.27) | 35 | 0.77 (0.22) |
| p Value* | <0.001 | <0.001 | <0.001 | <0.001 | ||||
| EQ-VAS baseline | ||||||||
| Resolved | 103 | 73.2 (17.4) | 19 | 73.1 (18.0) | 41 | 72.6 (17.8) | 43 | 73.7 (17.2) |
| Not resolved | 158 | 66.3 (20.6) | 32 | 64.5 (24.2) | 72 | 64.6 (19.8) | 54 | 70.0 (19.2) |
| p Value* | 0.004 | 0.187 | 0.034 | 0.285 | ||||
| EQ-VAS follow-up | ||||||||
| Resolved | 103 | 86.3 (11.6) | 19 | 81.5 (14.1) | 41 | 87.0 (10.6) | 43 | 87.7 (11.1) |
| Not resolved | 157 | 71.5 (19.4 | 31 | 70.8 (21.6) | 73 | 69.0 (20.5) | 54 | 75.4 (16.1) |
| p Value* | <0.001 | 0.061 | <0.001 | <0.001 | ||||
| n | Median (IQR) | n | Median (IQR) | n | Median (IQR) | n | Median (IQR) | |
| Experience | ||||||||
| Resolved | 100 | 10 (8–10) | 18 | 9.5 (7.75–10) | 41 | 10 (9–10) | 41 | 10 (8–10) |
| Not resolved | 155 | 10 (8–10) | 30 | 9 (7.75–10) | 73 | 10 (8–10) | 52 | 10 (8.25–10) |
| p Value† | 0.77 | 0.46 | 0.958 | 0.201 | ||||
| MISS 21 scores | ||||||||
| TOTAL score | ||||||||
| Resolved | 90 | 5.38 (4.71–6.15) | 15 | 5.48 (4.95–6.62) | 37 | 6.05 (5.19–6.69) | 38 | 4.74 (4.14–5.48) |
| Not resolved | 119 | 5.00 (4.48–5.90) | 26 | 5.31 (4.79–6.01) | 56 | 5.19 (4.81–6.37) | 37 | 4.43 (4.00–5.02) |
| p Value† | 0.047 | 0.291 | 0.015 | 0.116 | ||||
| Distress | ||||||||
| Resolved | 90 | 5.00 (4.17–6.00) | 15 | 5.50 (5.00–7.00) | 37 | 6.00 (5.00–7.00) | 38 | 4.17 (4.00, 5.00) |
| Not resolved | 119 | 4.67 (4.0–5.67) | 26 | 5.33 (4.46–6.08) | 56 | 5.19 (4.21–6.0) | 37 | 4.00 (3.92, 4.50) |
| p Value† | 0.009 | 0.074 | 0.004 | 0.046 | ||||
| Communication | ||||||||
| Resolved | 90 | 5.00 (4.75–6.75) | 15 | 5.50 (5.00–7.00) | 37 | 6.50 (5.25–7.00) | 38 | 5.00 (4.25, 6.25) |
| Not resolved | 119 | 5.00 (4.50–6.25) | 26 | 5.13 (4.69–6.50) | 56 | 5.50 (5.00–7.00) | 37 | 4.75 (4.13, 5.50) |
| p Value† | 0.161 | 0.348 | 0.153 | 0.206 | ||||
| Rapport | ||||||||
| Resolved | 90 | 5.38 (4.50–6.28) | 15 | 5.75 (4.75–6.75) | 37 | 6.00 (5.38–6.88) | 38 | 4.56 (4.22, 5.38) |
| Not resolved | 119 | 5.00 (4.75–6.00) | 26 | 5.44 (4.84–6.31) | 56 | 5.25 (4.88–6.88) | 37 | 4.75 (4.00, 5.06) |
| p Value† | 0.834 | 0.668 | 0.403 | 0.5 | ||||
| Compliance intent | ||||||||
| Resolved | 90 | 5.50 (4.92–6.67) | 15 | 6.00 (5.00–6.67) | 37 | 6.00 (5.00–7.00) | 38 | 5.00 (4.00, 6.00) |
| Not resolved | 119 | 5.00 (4.33–6.00) | 26 | 5.17 (4.33–6.00) | 56 | 5.33 (5.00–6.33) | 37 | 4.43 (4.00, 5.00) |
| p Value† | 0.057 | 0.119 | 0.12 | 0.136 | ||||
*Independent samples t test for resolved versus not resolved.
†Mann-Whitney test for resolved versus not resolved.
ED, emergency department; MISS 21, Medicine Information Satisfaction Score; VAS, visual analogue scale.